Edition:
India

RaQualia Pharma Inc (4579.T)

4579.T on Tokyo Stock Exchange

1,295JPY
10 Dec 2019
Change (% chg)

¥-24 (-1.82%)
Prev Close
¥1,319
Open
¥1,315
Day's High
¥1,319
Day's Low
¥1,294
Volume
335,000
Avg. Vol
637,376
52-wk High
¥2,210
52-wk Low
¥785

Latest Key Developments (Source: Significant Developments)

RaQualia Pharma says license agreement for novel P2X7 receptor antagonist
Monday, 26 Mar 2018 

March 26(Reuters) - RaQualia Pharma Inc <4579.T>:Says it and Asahi Kasei Pharma Corp have entered into a license agreement for a novel P2X7 receptor antagonist discovered through a research collaboration between the two companies.  Full Article

RaQualia Pharma to sign license agreements with CJ HealthCare
Thursday, 28 Dec 2017 

Dec 28 (Reuters) - RaQualia Pharma Inc <4579.T>:Says it plans to sign license agreements with CJ HealthCare regarding RQ-00000004(tegoprazan) and crystal of RQ-00000004(tegoprazan) .  Full Article

RaQualia Pharma says termination of 5-HT4 partial agonist related license agreement
Thursday, 28 Dec 2017 

Dec 28 (Reuters) - RaQualia Pharma Inc <4579.T>:Says co and South Korea-based firm CJ HealthCare terminate 5-HT4 partial agonist (RQ-00000010) related license agreement .  Full Article

RaQualia Pharma signs license agreement with Maruho on selective Na sodium channel blocker
Monday, 25 Dec 2017 

Dec 25 (Reuters) - RaQualia Pharma Inc <4579.T> ::Says it and Maruho Co Ltd planed to enter into license agreement, regarding selective Na sodium channel blocker, on Dec. 25.  Full Article